AIMS: To investigate the association of CYP2A6 genetic polymorphisms with smoking-related phenotypes in Chinese smokers. DESIGN: Case-only genetic association study. SETTING: Southern China. PARTICIPANTS: A total of 1328 Han Chinese smokers who participated in a community-based chronic disease screening project in Guangzhou and Zhuhai from 2006 to 2007. MEASUREMENTS: All participants answered a structured questionnaire about socio-demographic status and smoking behaviors and informative alleles were genotyped for the cytochrome P450 2A6 (CYP2A6) gene (CYP2A6*4,*5,*7,*9 and *10). FINDINGS: The frequencies of CYP2A6*4, *5, *7, *9 and *10 alleles were 8.5, 1.2, 6.3, 13.5 and 2.4%, which corresponded to 48.9, 15.4, 24.2 and 11.5% of participants being classified as normal, intermediate, slow and poor metabolizers, respectively. Multivariate analyses in male smokers demonstrated that compared with normal metabolizers, poor metabolizers reported smoking fewer cigarettes per day [adjusted odds ratio (OR) = 0.49; 95% confidence interval (CI): 0.32-0.76], started smoking regularly later in life (adjusted OR = 1.55; 95% CI: 1.06-2.26) and, among former smokers, reported smoking for a shorter duration prior to quitting (adjusted OR = 0.33; 95% CI: 0.12-0.94). However, poor metabolizers were less likely to quit smoking and remain abstinent than normal metabolizers (adjusted OR = 0.54; 95% CI: 0.34-0.86). CONCLUSIONS: Reduced metabolism function of cytochrome P450 2A6 in smokers appears to be associated with fewer cigarettes smoked, later initiation of smoking regularly, shorter smoking duration and lower likelihood of smoking cessation.
AIMS: To investigate the association of CYP2A6 genetic polymorphisms with smoking-related phenotypes in Chinese smokers. DESIGN: Case-only genetic association study. SETTING: Southern China. PARTICIPANTS: A total of 1328 Han Chinese smokers who participated in a community-based chronic disease screening project in Guangzhou and Zhuhai from 2006 to 2007. MEASUREMENTS: All participants answered a structured questionnaire about socio-demographic status and smoking behaviors and informative alleles were genotyped for the cytochrome P450 2A6 (CYP2A6) gene (CYP2A6*4,*5,*7,*9 and *10). FINDINGS: The frequencies of CYP2A6*4, *5, *7, *9 and *10 alleles were 8.5, 1.2, 6.3, 13.5 and 2.4%, which corresponded to 48.9, 15.4, 24.2 and 11.5% of participants being classified as normal, intermediate, slow and poor metabolizers, respectively. Multivariate analyses in male smokers demonstrated that compared with normal metabolizers, poor metabolizers reported smoking fewer cigarettes per day [adjusted odds ratio (OR) = 0.49; 95% confidence interval (CI): 0.32-0.76], started smoking regularly later in life (adjusted OR = 1.55; 95% CI: 1.06-2.26) and, among former smokers, reported smoking for a shorter duration prior to quitting (adjusted OR = 0.33; 95% CI: 0.12-0.94). However, poor metabolizers were less likely to quit smoking and remain abstinent than normal metabolizers (adjusted OR = 0.54; 95% CI: 0.34-0.86). CONCLUSIONS: Reduced metabolism function of cytochrome P450 2A6 in smokers appears to be associated with fewer cigarettes smoked, later initiation of smoking regularly, shorter smoking duration and lower likelihood of smoking cessation.
Authors: C Lerman; C Jepson; E P Wileyto; F Patterson; R Schnoll; M Mroziewicz; N Benowitz; R F Tyndale Journal: Clin Pharmacol Ther Date: 2010-03-24 Impact factor: 6.875
Authors: Thorgeir E Thorgeirsson; Daniel F Gudbjartsson; Ida Surakka; Jacqueline M Vink; Najaf Amin; Frank Geller; Patrick Sulem; Thorunn Rafnar; Tõnu Esko; Stefan Walter; Christian Gieger; Rajesh Rawal; Massimo Mangino; Inga Prokopenko; Reedik Mägi; Kaisu Keskitalo; Iris H Gudjonsdottir; Solveig Gretarsdottir; Hreinn Stefansson; John R Thompson; Yurii S Aulchenko; Mari Nelis; Katja K Aben; Martin den Heijer; Asger Dirksen; Haseem Ashraf; Nicole Soranzo; Ana M Valdes; Claire Steves; André G Uitterlinden; Albert Hofman; Anke Tönjes; Peter Kovacs; Jouke Jan Hottenga; Gonneke Willemsen; Nicole Vogelzangs; Angela Döring; Norbert Dahmen; Barbara Nitz; Michele L Pergadia; Berta Saez; Veronica De Diego; Victoria Lezcano; Maria D Garcia-Prats; Samuli Ripatti; Markus Perola; Johannes Kettunen; Anna-Liisa Hartikainen; Anneli Pouta; Jaana Laitinen; Matti Isohanni; Shen Huei-Yi; Maxine Allen; Maria Krestyaninova; Alistair S Hall; Gregory T Jones; Andre M van Rij; Thomas Mueller; Benjamin Dieplinger; Meinhard Haltmayer; Steinn Jonsson; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Lambertus A Kiemeney; Jose I Mayordomo; Jes S Lindholt; Jesper Holst Pedersen; Wilbur A Franklin; Holly Wolf; Grant W Montgomery; Andrew C Heath; Nicholas G Martin; Pamela A F Madden; Ina Giegling; Dan Rujescu; Marjo-Riitta Järvelin; Veikko Salomaa; Michael Stumvoll; Tim D Spector; H-Erich Wichmann; Andres Metspalu; Nilesh J Samani; Brenda W Penninx; Ben A Oostra; Dorret I Boomsma; Henning Tiemeier; Cornelia M van Duijn; Jaakko Kaprio; Jeffrey R Gulcher; Mark I McCarthy; Leena Peltonen; Unnur Thorsteinsdottir; Kari Stefansson Journal: Nat Genet Date: 2010-04-25 Impact factor: 38.330
Authors: Naji C Salloum; Erica L F Buchalter; Swati Chanani; Gemma Espejo; Mahjabeen S Ismail; Randy O Laine; Maysaa Nageeb; A Benjamin Srivastava; Nicholas Trapp; Ludwig Trillo; Erica Vance; Michael Wenzinger; Sarah M Hartz; Sean P David; Li-Shiun Chen Journal: Pharmacogenomics Date: 2018-06-19 Impact factor: 2.533
Authors: Jian-Min Yuan; Heather H Nelson; Steven G Carmella; Renwei Wang; Jacquelyn Kuriger-Laber; Aizhen Jin; Jennifer Adams-Haduch; Stephen S Hecht; Woon-Puay Koh; Sharon E Murphy Journal: Carcinogenesis Date: 2017-04-01 Impact factor: 4.944
Authors: Brett R Winters; Tavleen K Kochar; Phillip W Clapp; Ilona Jaspers; Michael C Madden Journal: Chem Res Toxicol Date: 2020-06-18 Impact factor: 3.739
Authors: Li-Shiun Chen; Sarah M Hartz; Timothy B Baker; Yinjiao Ma; Nancy L Saccone; Laura J Bierut Journal: Pharmacogenomics Date: 2018-11-16 Impact factor: 2.533
Authors: Keran Jiang; Zhongli Yang; Wenyan Cui; Kunkai Su; Jennie Z Ma; Thomas J Payne; Ming D Li Journal: Nicotine Tob Res Date: 2019-05-21 Impact factor: 4.244